Exelixis Access Services (EASE) includes a set of personalized support programs that offer a full range of services designed to support healthcare providers and patients who are prescribed Cabometyx (cabozantinib) or Cometriq (cabozantinib).
Genentech Access Solutions offers a suite of programs and services to help facilitate access to Genentech BioOncology medicines for eligible patients. Support services include coverage and reimbursement assistance, financial assistance, and resource support.
Gilead Sciences Zydelig AccessConnect is a patient support program that offers ease of access and financial support for patients receiving treatment with Zydelig (idelalisib) who are unable to afford the medication.
Helsinn Therapeutics offers the Helsinn Cares program that supports access, reimbursement, and assistance for patients who are prescribed Akynzeo (netupitant and palonosetron) or Valchlor (mechlorethamine gel). Akynzeo is indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV). Valchlor is indicated for the topical treatment of stage IA/IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received skin-directed therapy.
Heron Therapeutics’s Heron Connect offers comprehensive support and access services for patients who have been prescribed Sustol (granisetron) extended-release injection and/or Cinvanti (aprepitant) injectable emulsion.
IncyteCARES (Connecting to Access, Reimbursement, Education, and Support) provides a single point of contact through a registered nurse to assist eligible patients and healthcare providers in obtaining access to Jakafi (ruxolitinib) and to connect them with continuing support and resources.
Ipsen Biopharmaceuticals provides several patient support services through its IPSEN CARES (Coverage, Access, Reimbursement, & Education Support) program to patients who are prescribed Onivyde (irinotecan liposome injection) or Soma-tuline Depot (lanreotide) injection.
Janssen Biotech, through Janssen CarePath, offers 1 source for patient support services, focused on access, affordability, and treatment support for patients who are prescribed a Janssen Biotech oncology medication.
Jazz Pharmaceuticals, through its JumpStart Program, offers patients support for its hematology/oncology drugs—Defitelio (defibrotide sodium), Erwinaze (asparaginase Erwinia chrysanthemi), and Vyxeos.